Shared on 04 Sep 25
Aging Population And Robotics Will Elevate Orthopedic Care
Following stronger-than-expected Q2 results, raised guidance, and increased optimism about future earnings growth, analysts maintained Zimmer Biomet Holdings’ consensus price target at $110.92. Analyst Commentary Increased confidence in Zimmer Biomet’s second half performance following solid Q2 results.
Shared on 07 May 25
Fair value Decreased 11%Aging Population And Robotics Will Elevate Orthopedic Care
Shared on 30 Apr 25
Fair value Increased 15%New Implants And Acquisition Integration Will Expand US Markets
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Fair value Decreased 12%New Implants And Acquisition Integration Will Expand US Markets
Shared on 16 Apr 25
Fair value Increased 0.065%New Implants And Acquisition Integration Will Expand US Markets
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 0.19%New Implants And Acquisition Integration Will Expand US Markets
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 1.04%New Implants And Acquisition Integration Will Expand US Markets
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
New Implants And Acquisition Integration Will Expand US Markets
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
New Implants And Acquisition Integration Will Expand US Markets
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Decreased 9.47%New Implants And Acquisition Integration Will Expand US Markets
AnalystConsensusTarget has decreased revenue growth from 4.4% to 3.7%.